Shenglin Ma
Overview
Explore the profile of Shenglin Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
210
Citations
2582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang J, Luo S, Shen J, Lee M, Chen R, Ma S, et al.
Oncogene
. 2025 Mar;
PMID: 40057606
Disrupted cellular polarity (DCP) is a hallmark of solid cancer, the malignant disease of epithelial tissues, which occupies ~90% of all human cancers. DCP has been identified to affect not...
2.
Li Y, Yu Q, Bu Q, Lin L, Ning F, Zhao Y, et al.
J Thorac Oncol
. 2025 Feb;
PMID: 39929333
Introduction: Retrospective studies have indicated the potential benefits of immunotherapy for brain metastases (BMs) in NSCLC. To our knowledge, CTONG 2003 is the first randomized controlled trial to evaluate camrelizumab...
3.
Xu C, Lian B, Ou J, Wang Q, Wang W, Wang K, et al.
Glob Med Genet
. 2024 Nov;
11(4):330-343.
PMID: 39583123
The fibroblast growth factor receptor (FGFR) is a crucial receptor tyrosine kinase involved in essential biological processes, including growth, development, and tissue repair. However, FGFR gene mutations, including amplification, fusion,...
4.
Zhang J, Wu Q, Zhu L, Xie S, Tu L, Yang Y, et al.
Cancer Lett
. 2024 Nov;
610:217337.
PMID: 39581824
No abstract available.
5.
Wang W, Lian B, Xu C, Wang Q, Li Z, Zheng N, et al.
Innovation (Camb)
. 2024 Nov;
5(6):100661.
PMID: 39529955
The BRAF gene is an important signaling molecule in human cells that is involved in the regulation of cell growth, differentiation, and survival. When the BRAF gene mutates, it can...
6.
Liang J, Zhu L, Li J, Wu K, Zhang M, Ma S, et al.
Discov Oncol
. 2024 Sep;
15(1):509.
PMID: 39347891
Background: Immunotherapy faces a major challenge in treatment resistance, highlighting the need for efficacy biomarkers identification. The tumor microenvironment (TME) significantly influences treatment outcomes, necessitating molecular TME exploration to address...
7.
Li C, Yu X, Han X, Lian C, Wang Z, Shao S, et al.
iScience
. 2024 Sep;
27(9):110750.
PMID: 39280627
Innate immune cells, crucial in resisting infections and initiating adaptive immunity, play diverse and significant roles in tumor development. These cells, including macrophages, granulocytes, dendritic cells (DCs), innate lymphoid cells,...
8.
Wang Y, Luo J, Bai M, Ma Z, Xu Y, Liu D, et al.
Drug Metab Dispos
. 2024 Sep;
52(11):1332-1344.
PMID: 39261014
Antifolates are important for chemotherapy in non-small cell lung cancer (NSCLC). They mainly rely on reduced folate carrier (RFC) and proton-coupled folate transporter (PCFT) to enter cells. PCFT is supposed...
9.
Wang W, Zhang X, Gui P, Zou Q, Nie Y, Ma S, et al.
BMC Cancer
. 2024 Sep;
24(1):1105.
PMID: 39237897
Background: SEPT9 is a pivotal cytoskeletal GTPase that regulates diverse biological processes encompassing mitosis and cytokinesis. While previous studies have implicated SEPT9 in tumorigenesis and development; comprehensive pan-cancer analyses have...
10.
Pan K, Wang B, Xu X, Liang J, Tang Y, Ma S, et al.
Discov Oncol
. 2024 Jul;
15(1):318.
PMID: 39078419
Background: Lung cancer is a common cause of brain metastases, approximately 40% of patients with lung cancer will develop brain metastases at some point during their disease. Hypofractionated stereotactic radiotherapy...